Received: 12 September 2019
Accepted: 6 April 2020
First Online: 22 April 2020
Ethics approval and consent to participate
: this project was approved be the CHPL’s ethics and scientific-pedagogical committees (Hospital deliberations: CCP 02/2019 e CES 02/2019, the IRB responsible for the approval of the study, the anonymity of the data delivered to the authors, and the supervision that the patients were not identified in any moment, having waived a formal consent), following the rules defined in the General Regulation of Data Protection.
: not applicable.
: The first author has presented on the behalf of Tecnifar pharmaceutical, regarding topics not related to the ones discussed in this study.